Yet another movement disorder lawsuit was filed against the various manufacturers of the brand-name drug Reglan and its generic equivalent, Metoclopramide. Hundreds of Reglan lawyers across the country are filing lawsuits similar to this one, which alleges that long-term use of Reglan leads to movement disorders. Ever since the FDA issued its black box warning for Reglan, there has been little scientific debate over whether users of Reglan could develop movement disorders like tardive dyskinesia. The legal battle is waged over whether the manufacturers adequately warned Reglan users of the risks of developing movement disorders.
44. This case involves, in part, Defendants' failure to warn doctors and patients
of information within their knowledge or possession which indicated that the
subject Reglan/metoclopramide, when taken for long periods of time, caused
serious, permanent and debilitating side effects, including tardive dyskinesia.45. Defendants jointly and severally marketed, manufactured and distributed
Reglan/metoclopramide and encouraged the long term use of these drugs,
misrepresented the effectiveness of these drugs and concealed the drug's dangerous
side effects.46. Reglan/metoclopramide is indicated as short-term therapy for symptomatic
gastroesophageal reflux and acute and recurrent diabetic gastric stasis.47. Reglan/metoclopramide is indicated for use for no greater than twelve weeks;
however, Defendants represented that Reglan/metoclopramide was safe for use to
treat nausea and/or esophageal reflux for durations that exceed twelve weeks.48. Patients who use Reglan/metoclopramide for long periods are at a significantly
increased risk of developing a severe and permanent neurological movement
disorder.
Continue reading "Movement Disorder Lawsuit Filed In Florida Against Reglan Manufacturers" »
